Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906034290> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2906034290 endingPage "S55" @default.
- W2906034290 startingPage "S55" @default.
- W2906034290 abstract "Recent biotherapies developed in oncology have shown bigger impact in specific populations with tumour profiles that match the drugs' mechanism. The aim of our study was to determine the impact of biomarker(BM)-based patient selection (PS) on clinical development (CD) and market-access (MA) compared to all-comers strategy. We built a multi-step prediction tool based on clinical trials and MA data available for biotherapies developed in hematologic an solid tumours since 2006. Trials were analysed based on whether or not patients were recruited through BM-selection. Trial success was considered when subsequent development phases were found for the treatment in a similar indication. For each CD phase and FDA application, we determined the probability of success. The probability of MA for biotherapeutic treatments with and without BM-based PS were compared by therapeutic area, depending on the clinical development phase when BM-based PS was introduced (1, 2 or 3). The overall probability of success for biotherapies developed with an all-comers recruitment strategy at all CD stages was 5% (9% in haematology and 4% in solid tumours) with the biggest hurdle being phase 2 (26% success). BM-based PS was associated with a noticeable increase in development success, reaching 15% (23% in haematology, 12% in solid tumours). Introduction of BM-based PS in phase 2 had the biggest impact compared to the other CD phases (up to 42% success). BM-based PS ensures a higher probability of CD and MA success, although it can lead to restrictions in eligible patients, which could lead to loss of opportunity for patients who may have benefitted of the treatment but were excluded from CD. The potential effect of BM-based PS on target population size as well as the impact of smaller population on price negotiations should be taken into consideration to determine the opportunity-cost related to this CD design choices." @default.
- W2906034290 created "2019-01-01" @default.
- W2906034290 creator A5005642081 @default.
- W2906034290 creator A5026059401 @default.
- W2906034290 creator A5063645267 @default.
- W2906034290 creator A5069571083 @default.
- W2906034290 creator A5071425286 @default.
- W2906034290 date "2018-10-01" @default.
- W2906034290 modified "2023-09-27" @default.
- W2906034290 title "PCN240 - ALL-COMERS VS. BIOMARKER BASED PATIENT SELECTION FOR BIOTHERAPIES IN ONCOLOGY: IMPACT ON DRUG DEVELOPMENT AND MARKET ACCESS" @default.
- W2906034290 doi "https://doi.org/10.1016/j.jval.2018.09.322" @default.
- W2906034290 hasPublicationYear "2018" @default.
- W2906034290 type Work @default.
- W2906034290 sameAs 2906034290 @default.
- W2906034290 citedByCount "0" @default.
- W2906034290 crossrefType "journal-article" @default.
- W2906034290 hasAuthorship W2906034290A5005642081 @default.
- W2906034290 hasAuthorship W2906034290A5026059401 @default.
- W2906034290 hasAuthorship W2906034290A5063645267 @default.
- W2906034290 hasAuthorship W2906034290A5069571083 @default.
- W2906034290 hasAuthorship W2906034290A5071425286 @default.
- W2906034290 hasBestOaLocation W29060342901 @default.
- W2906034290 hasConcept C126322002 @default.
- W2906034290 hasConcept C142724271 @default.
- W2906034290 hasConcept C143998085 @default.
- W2906034290 hasConcept C154945302 @default.
- W2906034290 hasConcept C185592680 @default.
- W2906034290 hasConcept C194409129 @default.
- W2906034290 hasConcept C2780035454 @default.
- W2906034290 hasConcept C2781197716 @default.
- W2906034290 hasConcept C31760486 @default.
- W2906034290 hasConcept C40423286 @default.
- W2906034290 hasConcept C41008148 @default.
- W2906034290 hasConcept C535046627 @default.
- W2906034290 hasConcept C55493867 @default.
- W2906034290 hasConcept C64903051 @default.
- W2906034290 hasConcept C71924100 @default.
- W2906034290 hasConcept C81917197 @default.
- W2906034290 hasConcept C98274493 @default.
- W2906034290 hasConceptScore W2906034290C126322002 @default.
- W2906034290 hasConceptScore W2906034290C142724271 @default.
- W2906034290 hasConceptScore W2906034290C143998085 @default.
- W2906034290 hasConceptScore W2906034290C154945302 @default.
- W2906034290 hasConceptScore W2906034290C185592680 @default.
- W2906034290 hasConceptScore W2906034290C194409129 @default.
- W2906034290 hasConceptScore W2906034290C2780035454 @default.
- W2906034290 hasConceptScore W2906034290C2781197716 @default.
- W2906034290 hasConceptScore W2906034290C31760486 @default.
- W2906034290 hasConceptScore W2906034290C40423286 @default.
- W2906034290 hasConceptScore W2906034290C41008148 @default.
- W2906034290 hasConceptScore W2906034290C535046627 @default.
- W2906034290 hasConceptScore W2906034290C55493867 @default.
- W2906034290 hasConceptScore W2906034290C64903051 @default.
- W2906034290 hasConceptScore W2906034290C71924100 @default.
- W2906034290 hasConceptScore W2906034290C81917197 @default.
- W2906034290 hasConceptScore W2906034290C98274493 @default.
- W2906034290 hasLocation W29060342901 @default.
- W2906034290 hasOpenAccess W2906034290 @default.
- W2906034290 hasPrimaryLocation W29060342901 @default.
- W2906034290 hasRelatedWork W1756140406 @default.
- W2906034290 hasRelatedWork W2009224795 @default.
- W2906034290 hasRelatedWork W2114281628 @default.
- W2906034290 hasRelatedWork W2372770165 @default.
- W2906034290 hasRelatedWork W2388075619 @default.
- W2906034290 hasRelatedWork W2470067656 @default.
- W2906034290 hasRelatedWork W2528167051 @default.
- W2906034290 hasRelatedWork W2936512011 @default.
- W2906034290 hasRelatedWork W4285797485 @default.
- W2906034290 hasRelatedWork W2188607138 @default.
- W2906034290 hasVolume "21" @default.
- W2906034290 isParatext "false" @default.
- W2906034290 isRetracted "false" @default.
- W2906034290 magId "2906034290" @default.
- W2906034290 workType "article" @default.